Characteristics of the patients at discharge from the hospital
| Statin user | Total | ||
| Yes | No | ||
| Subjects n | 118 | 736 | 854 |
| Pneumonia | |||
| Yes | 53 (44.9) | 322 (43.8) | 375 (43.9) |
| No | 65 (55.1) | 414 (56.3) | 479 (56.1) |
| Sex | |||
| Male | 70 (59.3) | 344 (46.7) | 414 (48.5) |
| Female | 48 (40.7) | 392 (52.1) | 440 (51.5) |
| Age yrs | 68.5±8.4 | 71.1±11.6 | 70.8±11.2 |
| Spirometry | |||
| FVC L | 2.50±0.81 | 2.21±0.83 | 2.25±0.83 |
| FVC % pred | 77.4±20.4 | 71.1±23.1 | 72.1±22.8 |
| FEV1 L | 1.36±0.51 | 1.16±0.56 | 1.19±0.56 |
| FEV1 % pred | 52.4±16.6 | 46.7±20.2 | 47.6±19.8 |
| Spirometry missing | 24 (20.3) | 212 (28.8) | 236 (27.6) |
| Smoking habits | |||
| Never smoker | 10 (8.5) | 49 (6.7) | 59 (6.9) |
| Former smoker | 43 (36.4) | 277 (37.5) | 320 (37.5) |
| Current smoker | 60 (50.9) | 382 (51.9) | 442 (51.8) |
| Missing data | 5 (4.2) | 28 (3.8) | 33 (3.9) |
| Comorbidity | |||
| Lung cancer | 6 (5.1) | 26 (3.5) | 32 (3.8) |
| Cancer at other sites | 7 (5.9) | 64 (8.7) | 71 (8.3) |
| Ischaemic heart disease | 73 (61.9) | 170 (23.1) | 243 (28.5) |
| Congestive heart failure | 29 (24.6) | 140 (19.0) | 169 (19.8) |
| Atrial fibrillation | 20 (16.7) | 147 (20.0) | 167 (19.6) |
| Cerebrovascular disease | 16 (13.6) | 51 (6.9) | 67 (7.9) |
| Peripherial vascular disease | 17 (14.4) | 40 (3.0) | 28 (3.0) |
| Arterial hypertension | 44 (37.3) | 135 (18.3) | 179 (21.1) |
| Diabetes | 25 (21.2) | 77 (10.5) | 102 (11.9) |
| Venous thrombembolism | 3 (2.5) | 18 (2.5) | 21 (2.5) |
| Concomitant treatment | |||
| ACEI or ARB | 37 (31.6) | 142 (19.3) | 179 (21.0) |
| β-blockers | 44 (37.6) | 67 (9.1) | 111 (13.0) |
| Acetyl salicylate | 59 (50.0) | 165 (22.5) | 224 (26.3) |
| Warfarin | 16 (13.7) | 68 (9.3) | 84 (9.9) |
| Inhaled corticosteroids | 79 (67.0) | 462 (62.8) | 541 (63.4) |
| Long-term oxygen therapy | 5 (4.3) | 65 (8.9) | 70 (8.3) |
Data are presented as n (%) or mean±sd, unless otherwise stated. FVC: forced vital capacity; % pred: % predicted; FEV1: forced expiratory volume in one second; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker.